Stand up for the facts!
Our only agenda is to publish the truth so you can be an informed participant in democracy.
We need your help.
I would like to contribute
If Your Time is short
Gender-affirming care refers to an individualized health care model that prioritizes encouraging and supporting a person’s gender identity.
Before puberty, this care includes things like using the name and pronouns that align with a child’s gender identity. At older ages, it can include evidence-based medical treatments such as puberty blockers or hormone therapies. Gender-affirming surgical procedures are not commonly recommended or provided to minors.
Experts said gender-affirming treatments such as puberty blockers and hormone therapies are not experimental.
The word "experimental" can trigger fear of the unknown and may suggest unforeseeable consequences or complications.
"All ‘gender affirming care’ for children is 100% experimental," read the Instagram post featuring a screenshot of a tweet. "There are zero long term studies on the effects the drugs and surgeries will have on them."
This post was flagged as part of Facebook’s efforts to combat false news and misinformation on its News Feed. (Read more about our partnership with Meta, which owns Facebook and Instagram.)
(Screenshot from Instagram.)
Gender-affirming care is an individualized approach to health care that centers, encourages and supports a person’s gender identity, experts said.
The World Professional Association for Transgender Health’s standards of care noted that gender-affirming care is more than just transition-related medical treatments such as hormone therapy or surgical procedures.
Gender-affirming care for children might include allowing a child to wear whatever clothes they like or encouraging the use of the name and pronouns that align with the child’s gender identity, said Dr. Michelle Forcier, a pediatrics professor who specializes in gender and sexual and reproductive health at The Warren Alpert Medical School of Brown University.
Those types of emotional and social affirmation — which also include creating a safe space to explore gender identity — are important elements of pediatric gender-affirming care, said Dr. Jason Rafferty, a pediatrician and child psychiatrist at Hasbro Children’s Hospital in Providence, Rhode Island.
Forcier and Rafferty emphasized that gender-affirming care for children is based on individual needs and goals. Social support is the only type of gender-affirming care recommended for children before puberty, said Shane Diamond, a World Professional Association for Transgender Health spokesperson. As children reach adolescence, medical treatments might become part of their care.
Dr. Renata Arrington-Sanders, an adolescent and young adult medicine associate professor at Johns Hopkins University School of Medicine, said there is "an extensive body of evidence-based, peer reviewed research on gender-affirming care" that informs current standards set by organizations, including the Endocrine Society, the American Academy of Pediatrics, and the World Professional Association for Transgender Health.
Puberty-blocking medication might be an element of gender-affirming care for children who reach puberty and experience gender dysphoria — a feeling of distress when their bodies don’t align with their gender identity.
Puberty blockers "help delay unwanted physical changes that don’t match someone’s gender identity," according to St. Louis Children’s Hospital. They were first used in the U.S. for gender-affirming care in 2007, Rafferty said. But they have been prescribed in Europe at least since the mid-1990s to treat adolescents with persistent gender dysphoria.
The medication gives children time to explore their identities and consider additional treatment options. Research, including a 22-year follow-up study, shows that medication helps alleviate psychological distress in adolescence and supports a child’s development into adulthood.
Although puberty blockers weren't designed for gender-affirming care, their use for this purpose has been studied and isn't considered "experimental" by experts.
"‘Experimental’ in this context is a political term designed to create drama, confusion, and terror," said Forcier. "Medical care is always being evaluated and studied so we can provide the best care."
Every medication has side effects, Arrington-Sanders said, but doctors monitor the side effects of medications used to suppress puberty.
Studies demonstrate the long-term efficacy and positive impacts that gender-affirming care such as puberty blockers has on transgender youth, said C.P. Hoffman, senior policy counsel at the National Center for Transgender Equality. Hoffman pointed to a gender dysphoria research overview by doctors and researchers at the Yale School of Medicine, the University of Alabama at Birmingham, Children’s Medical Center Dallas and other institutions.
California state Sen. Scott Wiener, D-San Francisco, discusses his proposed measure to provide legal refuge to displaced transgender youth and their families on March 17, 2022, at a news conference in Sacramento, California. (AP)
Feminizing or masculinizing hormone therapies might be another element of gender-affirming care that may be recommended when a patient is capable of giving informed consent — around age 16, according to the Endocrine Society.
Like puberty blockers, gender-affirming hormone therapy medications aren’t approved specifically for gender affirmation use, and instead are approved and commonly used for contraception, managing menopause, for male pattern baldness and more.
But the hormones themselves are "considered safe (and) effective, especially when medically monitored," said Forcier of Brown University.
Gender-affirming surgeries are typically recommended for and provided to adults.
Certain gender-affirming surgeries, such as masculinizing chest surgery, are sometimes provided to teenagers, though this is rare. There is not much research on the long-term impact they have on adolescents, Rafferty said.
Some things about gender-affirming care, such as how it affects fertility, are still being researched. But experts said this is the nature of medicine and pediatrics.
Rafferty said, "When most people hear ‘experimental’ they feel it means that providers do not know what they are doing or (are) guessing when making clinical decisions." But additional studies and research happen routinely to learn more about a topic and to develop better practices and standards of care.
An Instagram post claimed, "All ‘gender affirming care’ for children is 100% experimental. There are zero long term studies on the effects the drugs and surgeries will have on them."
Experts said it is inaccurate to call all gender-affirming care for children "experimental," because the approach, including the use of puberty blockers, is evidence-based. Research also shows that gender-affirming care reduces the risk of suicide, anxiety, depression and gender dysphoria.
For prepubescent children, gender-affirming care does not involve medication or surgeries; instead, it’s about social affirmation such as allowing a child to wear gender-affirming clothes or adopt a gender-affirming hairstyle.
There’s an element of truth to the claim: There aren’t many long-term studies on the effects of gender-affirming surgeries for youth, but that’s because they aren’t done on children and rarely on teenagers.
We rate this post Mostly False.
PolitiFact researcher Caryn Baird contributed to this report.
Instagram post, Jan. 1, 2023
The Texas Tribune, What is gender-affirming medical care for transgender children? Here’s what you need to know, Aug. 4, 2021
Association of American Medical Colleges, What is gender-affirming care? Your questions answered, April 12, 2022
Them, Everything you need to know about feminizing hormone therapy, Aug. 16, 2022
International Journal of Transgender Health, Is puberty delaying treatment ‘experimental treatment’? April 11, 2020
SpringerLink, Pubertal delay as an aid in diagnosis and treatment of a transsexual adolescent, June 8, 1998
World Professional Association for Transgender Health, WPATH Standards of care for the health of transgender and gender diverse people version 8, Sept. 15, 2022
Email interview with Dr. Michelle Forcier, a professor of pediatrics at The Warren Alpert Medical School of Brown University, Jan. 6, 2023
Interview with Dr. Renata Arrington-Sanders, an associate professor of adolescent and young adult medicine at Johns Hopkins University School of Medicine, Jan. 6, 2023
Emailed statement from C.P. Hoffman, senior policy counsel at the National Center for Transgender Equality, Jan. 9, 2023
World Health Organization, Gender, accessed Jan. 9, 2023
American Academy of Pediatrics, Ensuring comprehensive care and support for transgender and gender-diverse children and adolescents, published October 2018
Emailed statement from R.J. Mills, a spokesperson with the American Medical Association, Jan. 9, 2023
Email exchange with Dr. Jennifer Evans, a clinical psychologist at the University of Florida, Jan. 6, 2023
Email interview with Shane Diamond, a spokesperson for the World Professional Association for Transgender Health, Jan. 9, 2023
Department of Health and Human Services Office of Population Affairs, Gender-affirming care and young people, accessed Jan. 10, 2023
Healthline, Everything you need to know about gender affirming care, May 27, 2022
American Medical Association, What to know about gender-affirming care for younger patients, Dec. 21, 2021
Psychology Today, The evidence for trans youth gender-affirming medical care, Jan. 24, 2022
Email interview Dr. Jason Rafferty, a pediatrician and child psychiatrist at Hasbro Children’s Hospital, Jan. 10, 2023
Science-Based Medicine, Gender-affirming care is not "experimental," June 25, 2022
What We Know Project at Cornell University, What does the scholarly research say about the effect of gender transition on transgender well-being? accessed Jan. 10, 2023
National Library of Medicine, Ten common questions (and their answers) about off-label drug use, published October 2012
The Journal of Clinical Endocrinology & Metabolism, Endocrine treatment of gender-dysphoric/gender-incongruent persons: An Endocrine Society clinical practice guideline, published November 2017
St. Louis Children’s Hospital, Puberty blockers, accessed Jan. 10, 2023
Mayo Clinic, Pubertal blockers for transgender and gender-diverse youth, accessed Jan. 10, 2023
The Association for Child and Adolescent Mental Health, Review: Puberty blockers for transgender and gender diverse youth—a critical review of the literature, Dec. 15, 2020
Trans Care BC, Puberty blockers for youth, accessed Jan. 10, 2023
Archives of Sexual Behavior, Puberty suppression in a gender-dysphoric adolescent: A 22-year follow-up, April 19, 2011
National Library of Medicine, Trends in the "off-label" use of GnRH agonists among pediatric patients in the United States, published October 2018
U.S. Food and Drug Administration, FDA Approval: What it means, accessed Jan. 10, 2023
U.S. Food and Drug Administration, Highlights of prescribing information: Supprelin LA, accessed Jan. 10, 2023
American Psychological Association, The risks of earlier puberty, published March 2016
National Library of Medicine, Psychological support, puberty suppression, and psychosocial functioning in adolescents with gender dysphoria, published November 2015
Archives of Sexual Behavior, Perceptions of sex, gender, and puberty suppression: A qualitative analysis of transgender youth, June 1, 2016
JAMA Network, Mental health outcomes in transgender and nonbinary youths receiving gender-affirming care, Feb. 25, 2022
Pediatrics, Young adult psychological outcome after puberty suppression and gender reassignment, Published October 2014
Cleveland Clinic Health Essentials, What are puberty blockers? Jan. 10, 2022
The Journal of Sexual Medicine, Puberty suppression in adolescents with gender identity disorder: A prospective follow‐up study, Aug. 1, 2011
The Lancet Diabetes and Endocrinology, Puberty suppression in transgender children and adolescents, May 22, 2017
Healthline, Are puberty blockers reversible? What you should know before treatment, Nov. 9, 2022
The Lancet Child and Adolescent Health, Continuation of gender-affirming hormones in transgender people starting puberty suppression in adolescence: a cohort study in the Netherlands, Oct. 20, 2022
Stanford Medicine, Better mental health found among transgender people who started hormones as teens, Jan. 12, 2022
Journal of Adolescent Health, Chosen name use is linked to reduced depressive symptoms, suicidal ideation and behavior among transgender youth, March 30, 2018
Journal of Adolescent Health, Association of gender-affirming hormone therapy with depression, thoughts of suicide, and attempted suicide among transgender and nonbinary youth, Dec. 14, 2021
Yale School of Medicine, Flawed Medicaid report in Florida, July 8, 2022
NBC, Florida medical board votes to ban gender-affirming care for transgender minors, Oct. 29, 2022
Gender GP, Puberty blockers for transgender youth & bone health, Jan. 13, 2022
Politico, The transgender care that states are banning, explained, March 25, 2022
NBC, Texas AG says transition care for minors is child abuse under state law, Feb. 22, 2022
Frontiers in Endocrinology, Short-term effects of gender-affirming hormone therapy on dysphoria and quality of life in transgender individuals: A prospective controlled study, July 29, 2021
University of California, San Francisco Transgender Care, Initiating hormone therapy, June 17, 2016
CNN, Gender-affirming care, a ‘crucial’ process for thousands of young people in America, April 21, 2022
NHS England, Clinical commissioning policy: Prescribing of cross-sex hormones as part of the gender identity development service for children and adolescents, published August 2016
American Heart Association Hypertension, Gender-affirming hormone therapy, vascular health and cardiovascular disease in transgender adults, Oct. 28, 2019
PBS NewsHour, What medical treatments do transgender youth get? April 22, 2022
Read About Our Process
In a world of wild talk and fake news, help us stand up for the facts.